Delivery Order SPE2DB20D3103-SPE2DB25FM5K9
Award Date
1/31/25
Potential Completion Date
2/3/25
Potential Value
$6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D1109|SPE2DB25FN07K, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,404,006 units of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $1,720.56 and is a Firm Fixed Price Delivery Order, with a period of performance through November 13, 2024....
This federal contract award, with ID SPE2DB22D3011|SPE2DB25FP9CW, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4,567,117,508 units of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $27,367.50 and is a Firm Fixed Price Delivery Order that runs through February 3, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award, with an ID of SPE2DB22D2005|SPE2DB24FJFM4, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a pharmaceutical product used to treat nausea and vomiting. The contract has a ceiling value of $2,025.19 and an ultimate completion date of December 14, 2023. It is a firm-fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen...
This federal contract award, with the ID SPE2DB24D1007|SPE2DB24FBZWF, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $7,822.83 and is a firm fixed-price delivery order type, with a completion date of July 11, 2024. This award is part of a...
This federal contract award, with ID SPE2DB22D3011|SPE2DB25FP8NH, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,907,253 units of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The award has a ceiling value of $3,018.12 and a completion date of January 14, 2025. This appears to be a delivery order under a larger...
This federal contract award, with ID SPE2DB20D7066|SPE2DB24FC2FB, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $23,519.07 and is a firm fixed-price delivery order, with a completion date of June 5, 2024. This contract award is part of a...
This federal contract award, valued at $2,848.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,803,693 units of Ondansetron ODT 4 mg tablets, a medication commonly used to treat nausea and vomiting. The contract has a firm fixed-price pricing type and an ultimate completion date of June 5, 2024. This contract award is part of a larger Indefinite...
This federal contract award, valued at $1,822.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,269,056 units of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award, identified as SPE2DB20D3103|SPE2DB24FP1M5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,771.23 firm fixed-price delivery order is for the supply of 4,564,884,036 units of the pharmaceutical product Ondansetron ODT 4 mg Tablet, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of June 13, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FZ34U, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,594,726 units of Ondansetron HCL 4 mg Tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $4,675.12 and a completion date of December 4, 2024. This appears to be a Firm Fixed Price Delivery Order...